Advertisement
Screener

Aterian, Inc. (ATER) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

Aterian, Inc. Research and Development Expense

Aterian, Inc. (ATER) reported Research and Development Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-25.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2025-03-25

  • Aterian, Inc. research and development expense for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • Aterian, Inc. research and development expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
  • Aterian, Inc. research and development expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
  • Aterian, Inc. research and development expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
  • Aterian, Inc. research and development expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • Aterian, Inc. research and development expense for fiscal 2023 was $4.62M, a 23.22% decline from fiscal 2022.
  • Aterian, Inc. research and development expense for fiscal 2022 was $6.01M, a 38.88% decline from fiscal 2021.
  • Aterian, Inc. research and development expense for fiscal 2021 was $9.84M, a 21.00% increase from fiscal 2020.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25
$0.00
derived: sum of 2 quarters · filed 2025-03-25
$0.00
derived: sum of 3 quarters · filed 2025-03-25
$0.00
10-K · filed 2025-03-25
2024-09-30$0.00
10-Q · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
$808.00K
derived: sum of 4 quarters · filed 2025-03-25
2024-06-30$0.00
10-Q · filed 2024-08-09
$0.00
10-Q · filed 2024-08-09
$808.00K
derived: sum of 3 quarters · filed 2025-03-25
$1.66M
derived: sum of 4 quarters · filed 2025-03-25
2024-03-31$0.00
10-Q · filed 2024-05-15
$808.00K
derived: sum of 2 quarters · filed 2025-03-25
$1.66M
derived: sum of 3 quarters · filed 2025-03-25
$3.37M
derived: sum of 4 quarters · filed 2025-03-25
2023-12-31$808.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25
$1.66M
derived: sum of 2 quarters · filed 2025-03-25
$3.37M
derived: sum of 3 quarters · filed 2025-03-25
$4.62M
10-K · filed 2025-03-25
2023-09-30$852.00K
10-Q · filed 2024-11-12
$2.56M
derived: sum of 2 quarters · filed 2024-11-12
$3.81M
10-Q · filed 2024-11-12
$5.24M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$1.71M
10-Q · filed 2024-08-09
$2.96M
10-Q · filed 2024-08-09
$4.39M
derived: sum of 3 quarters · filed 2024-08-09
$6.09M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$1.25M
10-Q · filed 2024-05-15
$2.68M
derived: sum of 2 quarters · filed 2024-05-15
$4.38M
derived: sum of 3 quarters · filed 2024-05-15
$6.11M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$3.14M
derived: sum of 2 quarters · filed 2024-03-19
$4.87M
derived: sum of 3 quarters · filed 2024-03-19
$6.01M
10-K · filed 2024-03-19
2022-09-30$1.71M
10-Q · filed 2023-11-08
$3.44M
derived: sum of 2 quarters · filed 2023-11-08
$4.58M
10-Q · filed 2023-11-08
$7.20M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$1.73M
10-Q · filed 2023-08-09
$2.88M
10-Q · filed 2023-08-09
$5.49M
derived: sum of 3 quarters · filed 2023-08-09
$8.26M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$1.14M
10-Q · filed 2023-05-10
$3.76M
derived: sum of 2 quarters · filed 2023-05-10
$6.53M
derived: sum of 3 quarters · filed 2023-05-10
$8.85M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$2.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$5.38M
derived: sum of 2 quarters · filed 2023-03-16
$7.71M
derived: sum of 3 quarters · filed 2023-03-16
$9.84M
10-K · filed 2023-03-16
2021-09-30$2.77M
10-Q · filed 2022-11-09
$5.09M
derived: sum of 2 quarters · filed 2022-11-09
$7.22M
10-Q · filed 2022-11-09
$8.77M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$2.32M
10-Q · filed 2022-08-08
$4.45M
10-Q · filed 2022-08-08
$6.00M
derived: sum of 3 quarters · filed 2022-08-08
$7.85M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$2.12M
10-Q · filed 2022-05-10
$3.68M
derived: sum of 2 quarters · filed 2022-05-10
$5.52M
derived: sum of 3 quarters · filed 2022-05-10
$7.97M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$1.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16
$3.40M
derived: sum of 2 quarters · filed 2022-03-16
$5.85M
derived: sum of 3 quarters · filed 2022-03-16
$8.13M
10-K · filed 2022-03-16
2020-09-30$1.85M
10-Q · filed 2021-11-09
$4.30M
derived: sum of 2 quarters · filed 2021-11-09
$6.58M
10-Q · filed 2021-11-09
$9.51M
derived: sum of 4 quarters · filed 2022-03-16
2020-06-30$2.45M
10-Q · filed 2021-08-09
$4.73M
10-Q · filed 2021-08-09
$7.66M
derived: sum of 3 quarters · filed 2022-03-16
$10.89M
derived: sum of 4 quarters · filed 2022-03-16
2020-03-31$2.28M
10-Q · filed 2021-05-11
$5.21M
derived: sum of 2 quarters · filed 2022-03-16
$8.44M
derived: sum of 3 quarters · filed 2022-03-16
$11.78M
derived: sum of 4 quarters · filed 2022-03-16
2019-12-31$2.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16
$6.16M
derived: sum of 2 quarters · filed 2022-03-16
$9.50M
derived: sum of 3 quarters · filed 2022-03-16
$10.66M
10-K · filed 2022-03-16
2019-09-30$3.23M
10-Q · filed 2020-11-09
$2.63M
10-Q · filed 2019-11-05
$6.57M
derived: sum of 2 quarters · filed 2020-11-09
$7.73M
10-Q · filed 2020-11-09
$5.66M
10-Q · filed 2019-11-05
$8.58M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$3.34M
10-Q · filed 2020-07-30
$1.86M
10-Q · filed 2019-08-01
$4.50M
10-Q · filed 2020-07-30
$3.02M
10-Q · filed 2019-08-01
$5.35M
derived: sum of 3 quarters · filed 2020-07-30
$6.14M
derived: sum of 4 quarters · filed 2020-07-30
2019-03-31$1.16M
10-Q · filed 2020-05-11
$2.01M
derived: sum of 2 quarters · filed 2020-05-11
$2.80M
derived: sum of 3 quarters · filed 2020-05-11
$3.69M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$845.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-30
$1.64M
derived: sum of 2 quarters · filed 2020-03-30
$2.53M
derived: sum of 3 quarters · filed 2020-03-30
$3.65M
10-K · filed 2020-03-30
2018-09-30$790.00K
10-Q/A · filed 2020-03-30
$1.69M
derived: sum of 2 quarters · filed 2020-03-30
$2.81M
10-Q/A · filed 2020-03-30
2018-06-30$897.00K
10-Q/A · filed 2020-03-30
$2.02M
10-Q/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
HELEN OF TROY LTD (HELE)$0.685B-1.53